U.S. AND EUROPE IN-VIVO PHARMACOLOGY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Purview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • U.S. and Europe In-vivo Pharmacology Market, By Service Type
     • U.S. and Europe In-vivo Pharmacology Market, By Application
     • U.S. and Europe In-vivo Pharmacology Market, By End User

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
   • Impact Analysis
   • Key Highlights
   • Regulatory Scenario
   • Product Launches/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Market Opportunities
   • Regulatory Scenario
   • Industry Trends

4. U.S. and Europe In-vivo Pharmacology Market, By Service Type, 2021-2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Toxicology studies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • PK and PD Studies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Maximum Tolerated Dose Studies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Biomarkers Testing and Bio analysis
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Animal Disease Models
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • ADME studies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. U.S. and Europe In-vivo Pharmacology Market, By Application, 2021-2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Oncology
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Inflammation and Immunology
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Cardiology
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Neurology
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Pain Management
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Fibrosis
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Metabolic Diseases
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Respiratory Diseases
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Infectious Diseases
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. U.S. and Europe In-vivo Pharmacology Market, By End User, 2021-2033, (USD Mn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022 - 2033
     • Segment Trends
   • Biotechnology and Pharmaceutical Companies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Contract Research Organizations (CROs)
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Competitive Landscape

   • Charles River Laboratories
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Labcorp Drug Development
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Pharmaron
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • ICON plc
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Parexel International
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Eurofins Scientific
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Evotec
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Inotiv
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Taconic Biosciences
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Altasciences
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies

8. Analyst Recommendations

   • Wheel of Fortune
   • Analyst View
   • Coherent Opportunity Map

9. References and Research Methodology

   • References
   • Research Methodology
   • About us

*Browse 32 market data tables and 28 figures on ‘In-vivo Pharmacology Market’– U.S. and Europe forecast to 2033